Updates on the Proposed Botulinum Toxin A Mechanisms of Action in Orofacial Pain: A Review of Animal Studies
Toxins · 2025
DOI: 10.3390/toxins17120567 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxins, 2025. Verfasst von Jaime Fabillar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, …. Hauptthemen laut MEDLINE: Facial Pain, Botulinum Toxins, Type A, Analgesics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology of Japan.
Abstract (Originalsprache)
Experimental animal models of orofacial pain have been instrumental in elucidating biological pathways underlying the antinociceptive effect of botulinum neurotoxin type A (BoNT/A). Although several mechanisms have been proposed to explain how BoNT/A relieves pain, the precise modes of action, particularly in the oral and maxillofacial areas, remain elusive. The purpose of this review was to synthesize and assess the latest proposed mechanisms of action through which BoNT/A attenuates orofacial pain in established animal models. A comprehensive search was conducted using the terms “botulinum neurotoxin,” “mechanism,” and “orofacial pain” or “trigeminal neuralgia.” Only animal studies involving the establishment of an orofacial pain model were selected. Additional relevant studies were identified through manual screening of cited references. Over the past five years, several animal pain models have been established to decipher the mechanisms underlying the BoNT/A-mediated antinociception in orofacial pain. The proposed mechanisms include retrograde transport, neuronal excitability regulation, neuropeptide inhibition, inflammatory modulation, and opioid system stimulation in both the peripheral and central nervous systems. Despite the insubstantial number of investigations and findings, BoNT/A exhibits multidimensional modulation of nociceptive responses and, therefore, remains a promising therapeutic agent for managing orofacial pain conditions, with animal studies consistently providing insights into the mechanism of its antinociceptive action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatognathic Function and Occlusal Reconstruction, Graduate School of Biomedical Sciences, Tokushima University, Tokushima 770-8504, Japan.
- College of Dentistry, Southwestern University PHINMA, Cebu 6000, Philippines.
- Department of Bacteriology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.
ORCID-Profile: Jaime Fabillar, Kazuyuki Koike, Yoshizo Matsuka
Förderung
- Ministry of Education, Culture, Sports, Science, and Technology of Japan
Zitieren
APA
Fabillar, J., Yamamoto, Y., Koike, K., Ikutame, D., & Matsuka, Y. (2025). Updates on the Proposed Botulinum Toxin A Mechanisms of Action in Orofacial Pain: A Review of Animal Studies. Toxins. https://doi.org/10.3390/toxins17120567
Vancouver
Fabillar J, Yamamoto Y, Koike K, Ikutame D, Matsuka Y. Updates on the Proposed Botulinum Toxin A Mechanisms of Action in Orofacial Pain: A Review of Animal Studies. Toxins. 2025. doi:10.3390/toxins17120567
BibTeX
@article{Fabillar2025,
author = {Fabillar, Jaime and Yamamoto, Yumiko and Koike, Kazuyuki and Ikutame, Daisuke and Matsuka, Yoshizo},
title = {Updates on the Proposed Botulinum Toxin A Mechanisms of Action in Orofacial Pain: A Review of Animal Studies},
journal = {Toxins},
year = {2025},
doi = {10.3390/toxins17120567}
}
EUVIMED